User profiles for Francois Lamontagne

Francois Lamontagne

Université de Sherbrooke
Verified email at USherbrooke.ca
Cited by 27124

[HTML][HTML] Intravenous vitamin C in adults with sepsis in the intensive care unit

F Lamontagne, MH Masse, J Menard… - … England Journal of …, 2022 - Mass Medical Soc
Background Studies that have evaluated the use of intravenous vitamin C in adults with
sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown …

Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial

F Lamontagne, A Richards-Belle, K Thomas… - Jama, 2020 - jamanetwork.com
Importance Vasopressors are commonly administered to intensive care unit (ICU) patients
to raise blood pressure. Balancing risks and benefits of vasopressors is a challenge, …

Critically ill patients with 2009 influenza A (H1N1) infection in Canada

…, T Stelfox, S Bagshaw, K Choong, F Lamontagne… - Jama, 2009 - jamanetwork.com
Context Between March and July 2009, the largest number of confirmed cases of 2009
influenza A(H1N1) infection occurred in North America. Objective To describe characteristics, …

Drug treatments for covid-19: living systematic review and network meta-analysis

…, JPD Martinez, A Izcovich, B Rochwerg, F Lamontagne… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial

…, HT Stelfox, D Niven, J Muscedere, F Lamontagne… - Jama, 2021 - jamanetwork.com
Importance Growing interest in microbial dysbiosis during critical illness has raised
questions about the therapeutic potential of microbiome modification with probiotics. Prior …

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

…, C Green, R Haniffa, N Ichihara, F Lamontagne… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

A living WHO guideline on drugs for covid-19

…, BJ Hunt, M Stegemann, B Rochwerg, F Lamontagne… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …

[HTML][HTML] A living WHO guideline on drugs to prevent covid-19

F Lamontagne, M Stegemann, A Agarwal, T Agoritsas… - bmj, 2021 - bmj.com
Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

…, AM Higgins, TE Hills, CM Horvat, F Lamontagne… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis

…, D Cook, L Brochard, JCM Richard, F Lamontagne… - Jama, 2010 - jamanetwork.com
Context Trials comparing higher vs lower levels of positive end-expiratory pressure (PEEP)
in adults with acute lung injury or acute respiratory distress syndrome (ARDS) have been …